The Latest Breaking News from Wedbush

Musk publicly named a successor for the Twitter CEO job, and many Tesla investors and analysts are hopeful it will give him more time to focus on the  EV maker.

Investors in Asia seem to be betting bigger on American A.I. than China's.

Although bullish investors of SoFi Technologies appear enthused about Monday’s discount, SOFI stock may incur a longer-term challenge.

Apple scored over $117 billion in earnings in the first quarter but down 5% from last year as the company continues to thrive.

"Apple and Cook are in a position to gain market share and hire talent," Wedbush Securities analyst Dan Ives says.

Marketing is one of McDonald's "primary competitive edges," says Wedbush analyst Nick Setyan.

Morning Markets June S&P 500 futures (ESM2 3) this morning are down -0.12%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.37%. U.S. stock index futures this morning are modestly lower after today’s weekly jobless claims showed the U.S. labor market continues to soften. Continuing claims, which include...

Apple fans are watching to see whether the iPhone-maker puts a culture-changing spin on virtual reality, even as rivals slow their march toward the metaverse. All eyes are on whether Apple will commit to releasing long-rumored VR or augmented reality (AR) "goggles" at its annual Worldwide Developers Conference in June,…

Wedbush analyst and long-time Tesla bull Dan Ives says the EV maker has much higher margins than the industry even after the price cuts earlier this year.

Growing concerns about the safety of bank deposits have prompted investors to approach community and regional banks with caution

Apellis Pharmaceuticals’ (APLS) stock has jumped more than 25% year-to-date based on FDA approval for treating geographic atrophy. Despite the breakthrough, the company’s ability to scale up production remains a concern. Moreover, its closest competitor is also close to getting approval. Given its poor financials, stretched valuation, and weak profitability,…